Chao Luo

Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study

C. Zheng, Hui Zhao, Jun Zhou, 2019, Translational cancer research.

CMAR_A_187203 941..956

C. Zheng, Hui Zhao, Jun Zhou, 2020 .

Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients.

C. Zheng, Hui Zhao, Jun Zhou, 2019, American journal of translational research.

Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.

C. Zheng, Hui Zhao, Jun Zhou, 2020, Clinics and research in hepatology and gastroenterology.

Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study

C. Zheng, Hui Zhao, B. Liang, 2020, Cancer management and research.

Comparison of chemoembolization with CalliSpheres ® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study

C. Zheng, Hui Zhao, Jun Zhou, 2020 .

Comparison of chemoembolization with CalliSpheres ® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study

C. Zheng, Hui Zhao, Jun Zhou, 2020 .